PMID- 15695021 OWN - NLM STAT- MEDLINE DCOM- 20050315 LR - 20231213 IS - 0300-483X (Print) IS - 0300-483X (Linking) VI - 208 IP - 3 DP - 2005 Mar 30 TI - The effects of gestational arsenic exposure and dietary selenium deficiency on selenium and selenoenzymes in maternal and fetal tissues in mice. PG - 357-65 AB - Although toxicological and metabolic interactions of arsenic (As) and selenium (Se) have been suggested by epidemiolgical literatures, the past experimental studies mostly focused on acute, high-dose interaction, leaving the long-term, low-dose interaction unexplored. In the present study pregnant mice, fed either Se-deficient or adequate (0 or 5 micromol Se/kg diet, respectively) diet, were given oral gavage of sodium arsenite (0 or 58 micromol/kg per day; chosen as less than half of the fetotoxic dose in this protocol) from gestational day (GD) 7-16. The levels of As and Se as well as five selenoenzymes (glutathione peroxidase (GPx), thioredoxin reductase (TRxR), and type-I, -II and -III iodothyronine deiodinases (DI-I, -II and -III) were examined on GD17 in the tissues of dams and of fetus. The Se-deficient mice showed significantly enhanced accumulation of As compared to the Se-adequate mice in maternal liver (increased by 48%) and fetal brain (by 31%). Although no direct evidence of the enhanced toxicity in the Se-deficient group was obtained, the As exposure affected the levels of Se and selenoenzymes, an effect which was more discernible in Se-deficient group. Although most of theses changes were mild or moderate, the DI-II activity in Se-deficient fetal brain showed a drastic four-fold increase by As exposure, suggesting a possible disturbance of thyroid hormone environment in the fetus. These data suggested that apparently non-toxic, in utero dose of As, showed enhanced accumulation when combined with Se-deficiency and could affect the metabolism/kinetics of Se in fetal brain, which might result in developmental toxicity in mice. FAU - Miyazaki, Kaori AU - Miyazaki K AD - Department of Public Health, Division of Environmental Medicine, Gunma University Graduate School of Medicine, 3-39-22, Maebashi City, Gunma 371-8510, Japan. kmiyazak@med.gunma-u.ac.jp FAU - Watanabe, Chiho AU - Watanabe C FAU - Mori, Kouki AU - Mori K FAU - Yoshida, Katusmi AU - Yoshida K FAU - Ohtsuka, Ryutaro AU - Ohtsuka R LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Ireland TA - Toxicology JT - Toxicology JID - 0361055 RN - 0 (Arsenites) RN - 0 (Enzyme Inhibitors) RN - 0 (Sodium Compounds) RN - 0 (Water Pollutants, Chemical) RN - 48OVY2OC72 (sodium arsenite) RN - EC 1.11.1.- (iodothyronine deiodinase type I) RN - EC 1.11.1.- (iodothyronine deiodinase type III) RN - EC 1.11.1.8 (Iodide Peroxidase) RN - EC 1.11.1.9 (Glutathione Peroxidase) RN - EC 1.8.1.9 (Thioredoxin-Disulfide Reductase) RN - H6241UJ22B (Selenium) SB - IM MH - Animals MH - Arsenites/*toxicity MH - Brain/drug effects/enzymology MH - Diet MH - Enzyme Inhibitors/*toxicity MH - Female MH - Fetus/drug effects/metabolism MH - Glutathione Peroxidase/metabolism MH - Iodide Peroxidase/metabolism MH - Liver/drug effects/enzymology MH - Maternal Exposure MH - *Maternal-Fetal Exchange MH - Mice MH - Mice, Inbred ICR MH - Placenta/drug effects/enzymology MH - Pregnancy MH - Selenium/analysis/*deficiency MH - Sodium Compounds/*toxicity MH - Thioredoxin-Disulfide Reductase/metabolism MH - Water Pollutants, Chemical/*toxicity MH - Iodothyronine Deiodinase Type II EDAT- 2005/02/08 09:00 MHDA- 2005/03/16 09:00 CRDT- 2005/02/08 09:00 PHST- 2004/08/30 00:00 [received] PHST- 2004/11/20 00:00 [revised] PHST- 2004/11/22 00:00 [accepted] PHST- 2005/02/08 09:00 [pubmed] PHST- 2005/03/16 09:00 [medline] PHST- 2005/02/08 09:00 [entrez] AID - S0300-483X(04)00670-5 [pii] AID - 10.1016/j.tox.2004.11.030 [doi] PST - ppublish SO - Toxicology. 2005 Mar 30;208(3):357-65. doi: 10.1016/j.tox.2004.11.030.